The European Consortium EURenOmics is devoted to improving the lives of patients affected by rare kidney diseases. In line with the objectives of the International Rare Disease Research Consortium (IRDiRC), it aims to develop novel tools that will allow making more accurate diagnoses, predicting the disease course and the efficacy of available treatments, and helping developing new and better therapies for rare kidney diseases.